Be in the know. 10 key reads for Tuesday…

  1. Two ‘insurance’ rate cuts from Fed in ’90s produced no big shocks to corporate bonds, Goldman Sachs says (MarketWatch)
  2. Growth Is Worth Paying Up for at Pfizer (Wall Street Journal)
  3. Draghi puts further ECB easing firmly on the table (Reuters)
  4. U.S. Treasuries ‘most crowded’ as investors flee risk: BAML survey (Reuters)
  5. Fed Models Suddenly Call for Stronger Than Expected GDP Growth (24/7 Wall Street)
  6. Contra-indicator?:  Investors Haven’t Been This Bearish Since 2008 Financial Crisis (Bloomberg)
  7. Boeing Drought Gives Way to Second-Day Slugfest: Air Show Update (Bloomberg)
  8. A Wall Street investment chief overseeing $26 billion breaks down why recession fears are overblown, even as the market clamors for Fed relief (Business Insider)
  9. Jefferies Analysts Are Out With Four Daring Summer Growth Stock Picks (24/7 Wall St.)
  10. What I Have To Offer You (Ray Dalio)

Be in the know. 10 key reads for Monday…

  1. Trials Near for Boeing 737 MAX Fix (Wall Street Journal)
  2. Boeing Says Grounded 737 Max May Resume Service This Year (Bloomberg)
  3. Pfizer to buy Array Biopharma for $10.64 billion ()
  4. The World Cries Out for Onion Derivatives (Wall Street Journal)
  5. The Fed is likely to drop ‘patient’ word this week, clearing way for July cut, economists say (CNBC)
  6. Iran, Russia talks raise hopes of progress on OPEC+ meeting date (Reuters)
  7. What the Fed Will Do This Week, and Why (Bloomberg)
  8. Case for Cutting Rates Can Be Found in Close Calls of the 1990s (Wall Street Journal)
  9. Gary Woodland Wins U.S. Open (Wall Street Journal)
  10. Meet the Art World’s Rising Stars (Wall Street Journal)